Results 191 to 200 of about 67,526 (234)

Genetic evidence for GLP1R agonists in non-ischaemic heart failure. [PDF]

ESC Heart Fail
Le NN, Gill D, Padmanabhan S.
europepmc   +1 more source

Leveraging PCORnet® to Advance Clinical Genetics and the Genomic Learning Health System. [PDF]

Med Care
Rothman RL, Peterson J, Kripalani S, Barrett JB, Bastarache L, Lenert L, Taylor B, Carnahan R, Waitman LR.   +8 more
europepmc   +1 more source

Integrating genetic insights into pain management and opioid use optimization in chronic pain and substance abuse populations. [PDF]

Explor Res Clin Soc Pharm
Jairoun AA, Al-Hemyari SS, Shahwan M, Al-Ghananeem AM, Alnuaimi GR, Porntaveetus T.   +5 more
europepmc   +1 more source

Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study. [PDF]

Pharmacogenomics J
Görnert C, Scherf-Clavel M, Weber H, Roll SC, Eckert A, Reif A, Hahn M.   +6 more
europepmc   +1 more source

Corrigendum to "Pharmacogenetics association with long-term clinical evolution in a kidney transplant patients cohort" [Curr. Res. Pharmacol. Drug Discov. 9 (2025) 100230]. [PDF]

Curr Res Pharmacol Drug Discov
Sendra L, Olivera-Pasquini GG, Zucchet EG, Genvigir FDV, Beneyto MI, Hernández-Jaras J, Herrero MJ, Aliño SF.   +7 more
europepmc   +1 more source

Pharmacogenomics and Opioid Efficacy in Sickle Cell Disease. [PDF]

Medicina (Kaunas)
Elshaikh RH, Babker AM, Hussein SE, Ahmed KAM, Sah AK, Alfeel AH.   +5 more
europepmc   +1 more source

Pattern Recognition Algorithms in Pharmacogenomics and Drug Repurposing-Case Study: Ribavirin and Lopinavir. [PDF]

Pharmaceuticals (Basel)
Calvo H, Islas-Díaz D, Hernández-Laureano E.   +2 more
europepmc   +1 more source

Understanding Non-Small-Cell Lung Cancer: Biology, Therapeutics and Drug Resistance. [PDF]

Biomedicines
Ahluwalia P, Kolhe R, Rojiani M.
europepmc   +1 more source